Metabolic Therapies: Perseo pharma is a preclinical stage biotech start-up developing a pipeline of digestive therapies based on a proprietary enzyme therapeutics nanotechnology platform.

Products, services, technology

Our pipeline is focused on digestive therapies for Exocrine Pancreatic Insufficiency, Acquired Lactase Deficiency, Congenital Sucrase Deficiency, and Phenylketonuria. Additionally, our enzyme therapeutics platform can be applied to Systemic Enzyme Replacement Therapies and Oncology.

Cooperation possibilities

Two of our pipeline products are being developed jointly with an industry player. Perseo pharma is open to such joint developments and to granting access to its proprietary enzyme therapeutics platform.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business